Exploring the role of neuroactive steroids in Tourette syndrome

探索神经活性类固醇在抽动秽语综合征中的作用

基本信息

  • 批准号:
    10656348
  • 负责人:
  • 金额:
    $ 19.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT / PROJECT SUMMARY Tourette syndrome (TS) is a disabling neurodevelopmental disorder characterized by motor and phonic tics. Available treatment strategies remain unsatisfactory, due to our limited knowledge of the biological foundations of this disorder. The studies proposed in this application will explore the mechanisms underlying two of the least well-understood biological characteristics of TS, namely its marked male predominance and stress sus- ceptibility. Studies from our group suggest that these features of TS are contributed by neuroactive steroids, a family of mediators implicated in sex and stress regulation. The typical age of onset of TS is 6-7 years, coinciding with adrenarche, a phase of adrenal maturation charac- terized by an upsurge in adrenal neuroactive steroids, such as dehydroepiandrosterone (DHEA) and its sulfate (DHEAS). In preliminary studies, we found that DHEA exacerbated tic-like responses in animal models of TS. Interestingly, the dose of DHEA needed to elicit TS-like responses in females is higher than those needed in males, possibly pointing to a mechanism of sex differences in TS. Stress reduces the ability of TS patients to suppress tics, but the underlying mechanisms remain unknown. Our studies in animal models indicate that this process may be due to the elevation of the neuroactive steroid allo- pregnanolone (AP) in the prefrontal cortex. By inhibiting the ability of the prefrontal cortex to suppress tics, AP promotes tic execution. In a pilot study, we found that tic suppression, a well-known stressful task in TS pa- tients, increases AP salivary levels. Furthermore, in another proof-of-concept study, we found that inhibiting AP synthesis led to a reduction in tic severity and facilitated voluntary control of tics in stressful situations. These findings lead us to hypothesize that TS patients exhibit alterations of the composition of their neuroac- tive steroid profiles, including: 1) an increase in baseline DHEA(S) levels in male TS patients, in correlation with lifetime severity; and 2) an exaggerated elevation in AP in response to acute stress. The two Aims of this proposal will test this hypothesis by: 1) comparing the baseline urinary steroidomic profile of TS-affected boys and girls with non-affected sex- and age-matched controls; and 2) charting the dynamic alterations in steroidomic salivary profiles in response to tic suppression. These studies will advance our un- derstanding of the endocrine mechanisms in TS and lead to the identification of potential biomarkers for the severity of tics and comorbid symptoms. In the long run, the results of these studies may open the way for the development of new therapies for TS that may reduce tic severity and increase patients' responsiveness to be- havioral interventions.
摘要/项目总结 抽动秽语综合征(TS)是一种以运动和语音抽动为特征的致残性神经发育障碍。 由于我们对生物学基础的了解有限,现有的治疗策略仍然不能令人满意 这种紊乱的原因。本申请中提出的研究将探索两种潜在的机制, TS的生物学特征,即其显着的男性优势和压力的影响, 感受性我们小组的研究表明,TS的这些特征是由神经活性类固醇引起的, 涉及性和压力调节的调解者家族。 TS的典型发病年龄为6-7岁,与肾上腺初发期一致,肾上腺初发期是肾上腺成熟的一个阶段。 其特征是肾上腺神经活性类固醇如脱氢表雄酮(DHEA)及其硫酸盐的激增 (DHEAS)。在初步研究中,我们发现DHEA加剧了TS动物模型中的抽动样反应。 有趣的是,在女性中引发TS样反应所需的DHEA剂量高于在女性中所需的剂量。 男性,可能指向TS性别差异的机制。 压力降低了TS患者抑制抽搐的能力,但其潜在机制尚不清楚。我们 动物模型的研究表明,这一过程可能是由于神经活性类固醇同种异体的升高, 前额叶皮层中的孕烷醇酮(AP)。通过抑制前额叶皮层抑制抽搐的能力, 促进抽搐执行。在一项初步研究中,我们发现,抽动抑制,一个众所周知的压力任务,在TS pa- 增加AP唾液水平。此外,在另一项概念验证研究中,我们发现抑制AP 合成导致抽搐严重程度的降低,并促进在紧张情况下对抽搐的自愿控制。 这些发现使我们假设TS患者表现出其神经活性成分的改变, 有效的类固醇特征,包括:1)男性TS患者的基线DHEA(S)水平增加, 与终身严重性;和2)在AP反应急性应激夸张的升高。 本提案的两个目的将通过以下方式检验这一假设:1)比较基线尿类固醇特征 TS受影响的男孩和女孩与非受影响的性别和年龄匹配的对照;和2)绘制动态 对抽动抑制反应的类固醇唾液分布的改变。这些研究将促进我们的联合国- 了解TS的内分泌机制,并导致鉴定潜在的生物标志物, 抽搐和共病症状的严重程度。从长远来看,这些研究的结果可能会为 开发新的治疗TS的方法,可以降低抽搐的严重程度,并增加患者对... 口头发言。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marco Bortolato其他文献

Marco Bortolato的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marco Bortolato', 18)}}的其他基金

Mechanisms of information-processing and executive deficits caused by sleep deprivation
睡眠剥夺引起的信息处理和执行缺陷的机制
  • 批准号:
    10886925
  • 财政年份:
    2023
  • 资助金额:
    $ 19.67万
  • 项目类别:
Disentangling the biological links between violence and alcohol use
解开暴力和酗酒之间的生物学联系
  • 批准号:
    10660813
  • 财政年份:
    2023
  • 资助金额:
    $ 19.67万
  • 项目类别:
Exploring the role of neuroactive steroids in Tourette syndrome
探索神经活性类固醇在抽动秽语综合征中的作用
  • 批准号:
    10464500
  • 财政年份:
    2022
  • 资助金额:
    $ 19.67万
  • 项目类别:
Exploring the role of microbiota and inflammation in tic fluctuations
探索微生物群和炎症在抽动波动中的作用
  • 批准号:
    10431544
  • 财政年份:
    2022
  • 资助金额:
    $ 19.67万
  • 项目类别:
Exploring the role of microbiota and inflammation in tic fluctuations
探索微生物群和炎症在抽动波动中的作用
  • 批准号:
    10612010
  • 财政年份:
    2022
  • 资助金额:
    $ 19.67万
  • 项目类别:
Exploring the role of the protocadherin CELSR3 in Tourette syndrome
探索原钙粘蛋白 CELSR3 在抽动秽语综合征中的作用
  • 批准号:
    10532254
  • 财政年份:
    2021
  • 资助金额:
    $ 19.67万
  • 项目类别:
Exploring the role of the protocadherin CELSR3 in Tourette syndrome
探索原钙粘蛋白 CELSR3 在抽动秽语综合征中的作用
  • 批准号:
    10358988
  • 财政年份:
    2021
  • 资助金额:
    $ 19.67万
  • 项目类别:
Exploring steroid-based therapies to reduce opioid abuse
探索基于类固醇的疗法以减少阿片类药物滥用
  • 批准号:
    9916192
  • 财政年份:
    2020
  • 资助金额:
    $ 19.67万
  • 项目类别:
Deciphering gene-environment interactions in pathological reactive aggression
解读病理性反应性攻击中的基因-环境相互作用
  • 批准号:
    10460716
  • 财政年份:
    2014
  • 资助金额:
    $ 19.67万
  • 项目类别:
Deciphering gene-environment interactions in pathological reactive aggression
解读病理性反应性攻击中的基因-环境相互作用
  • 批准号:
    9116021
  • 财政年份:
    2014
  • 资助金额:
    $ 19.67万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.67万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了